1.Johnson, AP, Pearson, A, Duckworth, G. Surveillance and epidemiology of MRSA bacteraemia in the UK. Journal of Antimicrobial Chemotherapy 2005; 56: 455–462.
2.Beasley, C, Florey, D.MRSA screening – Operational Guidance 2: Department of Health, 2008 [Letter].
3.Cooper, BS, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proceedings of the National Academy of Sciences USA 2004; 101: 10223–10228.
4.Bootsma, MC, Diekmann, O, Bonten, MJ. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proceedings of the National Academy of Sciences USA 2006; 103: 5620–5625.
5.Bhattacharya, D, et al. Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California. Journal of Clinical Microbiology 2007; 45: 1798–1803.
6.Groom, AV, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. Journal of the American Medical Association 2001; 286: 1201–1205.
7.Hussain, FM, Boyle-Vavra, S, Daum, RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatric Infectious Disease Journal 2001; 20: 763–767.
8.Carleton, HA, et al. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. Journal of Infectious Diseases 2004; 190: 1730–1738.
9.Millar, BC, et al. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). Journal of Hospital Infection 2007; 67: 109–113.
11.Standards Unit, Centre for Clinical Infections. Identification of Staphylococcus species, Micrococcus species and Rothia species. National Standard Method: BSOP ID: 7i2.1. 2007.
12.McClure, JA, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. Journal of Clinical Microbiology 2006; 44: 1141–1144.
13.Miller, R, et al. Is MRSA admission bacteraemia community-acquired? A case control study. Journal of Infection 2008; 56: 163–170.
14.Enright, MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008–1015.
15.Harmsen, D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. Journal of Clinical Microbiology 2003; 41: 5442–5448.
16.Gomes, AR, Westh, H, de Lencastre, H. Origins and evolution of methicillin-resistant Staphylococcus aureus clonal lineages. Antimicrobial Agents Chemotherapy 2006; 50: 3237–3244.
17.Pan, ES, et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus – and their relation to community-associated disease activity. Journal of Infectious Disease 2005; 192: 811–818.
18.Maudsley, J, et al. The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK. Journal of Hospital Infection 2004; 57: 258–262.
19.Wyllie, DH, Peto, TE, Crook, D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997–2003. British Medical Journal 2005; 331: 992.
20.Atkinson, SR, et al. The emergence of meticillin-resistant Staphylococcus aureus among injecting drug users. Journal of Infection 2009; 58: 339.